Home Epilepsy and Other Seizure Disorders NBTS Brain Tumor Clinical Trials Report: Q2 2020 - News & Blog

NBTS Brain Tumor Clinical Trials Report: Q2 2020 – News & Blog

It can be hard for patients and care partners to keep track of new clinical trial opportunities opening across the country, especially during the current public health crisis created by the coronavirus (COVID-19). However, there are many brain tumor clinical trials still actively enrolling patients, and this report provides a summary of the studies that have recently opened or started. To learn more about each trial, and contact the party responsible for enrolling patients, just follow the link provided under the brief description of each listing.


  • A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
    • Brief Description: This is a global, phase I/II, multicenter, open-label study. For phase I, the purpose of this study is to assess the maximum tolerated dose (MTD), recommended phase 2 dose (RP2D), preliminary efficacy, and…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

please help us fundraise (501c3 non-profit) : braincancer

I work with OurBrainBank, a start-up non-profit dedicated to moving glioblastoma from terminal to treatable, powered by patients.We're a registered 501c3 non-profit in the...

Cancer and Mental Health Re-post : braincancer

Hello!I would like to thank everyone who participated in my survey these past few months! I received a tremendous response and I truly, truly...

Recent Comments